Search Results - "Beukinga, Ingrid"

PubPharm (6)

1

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

in: The Journal of infection | Vol. 82, No. 1 (2021), p. 159-198

by Blairon, L. | Mokrane, S. | Wilmet, A. | +4

CommentOn: J Infect. 2020 Sep;81(3):420-426. - PMID 32504745

2

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies

in: Journal of medical virology | Vol. 93, No. 2 (2021), p. 803-811

by Tré-Hardy, M. | Wilmet, A. | Beukinga, I. | +4

3

Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time

in: Journal of medical virology | (07.01.2021)

by Blairon, L. | Piteüs, S. | Beukinga, I. | +1

4

Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods : Experiences of a general hospital

in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | Vol. 129 (2020), p. 104472

by Blairon, L. | Wilmet, A. | Beukinga, I. | +1

CommentOn: Front Med (Lausanne). 2020 May 08;7:225. - PMID 32574326

5

The role of serology for COVID-19 control : Population, kinetics and test performance do matter

in: The Journal of infection | Vol. 81, No. 2 (2020), p. e91-e92

by Tré-Hardy, M. | Blairon, L. | Wilmet, A. | +4

CommentIn: J Infect. 2020 Dec;81(6):e28-e30. - PMID 32739486

6

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

in: Clinical chemistry and laboratory medicine | Vol. 58, No. 8 (2020), p. 1357-1364

by Tré-Hardy, M. | Wilmet, A. | Beukinga, I. | +3

1
[1]